Market Overview:
The global actinic keratosis treatment market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Actinic keratosis, also known as solar keratosis, refers to a skin condition that develops on the sun-exposed areas of the body. It causes rough, scaly patches to appear on the hands, arms, lips, scalp, and other body parts that can further develop into a skin cancer called squamous cell carcinoma. Some of the commonly used treatments to remove actinic keratosis include cryotherapy, curettage, laser therapy, and photodynamic therapy. At present, the considerably expanding healthcare infrastructure and increasing need for preventive strategies for cancer are positively influencing the demand for actinic keratosis treatment worldwide.
Actinic Keratosis Treatment Market Trends:
The increasing prevalence of actinic keratosis due to ozone layer depletion and excessive sun exposure represents one of the key factors fueling the growth of the market. Additionally, the rising incidences of cancer, coupled with the escalating demand for minimally invasive (MI) procedures, is strengthening the market growth. Furthermore, leading manufacturers are introducing medications for the treatment of actinic keratosis in the form of cream and gel, which is impelling the market growth. Apart from this, numerous public and private groups are focusing on conducting campaigns to generate awareness about available treatments for actinic keratosis across the globe. This, along with significant investments in the research and development (R&D) activities to develop novel therapies with improved efficacy, convenient dosage, and reduced costs, is creating a favorable market outlook. The market is also driven by the introduction of topical treatment that reduces the risk of scarring. This treatment is also used for treating a wide area of visible and invisible lesions on the skin. Besides this, favorable reimbursement policies are anticipated to fuel the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global actinic keratosis treatment market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, drug type and distribution channel.
Breakup by Type:
Breakup by Drug Type:
- Fluorouracil
- Imiquimod
- Diclofenac
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Drug Stores and Retail Pharmacies
- Online Stores
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Almirall SA, Bausch Health Companies Inc., Biofrontera Inc., BioLineRx Ltd., Cipher Pharmaceuticals Inc, Galderma SA, Hill Dermaceuticals Inc., LEO Pharma A/S and Sun Pharmaceutical Industries Ltd.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Million |
| Segment Coverage |
Type, Drug Type, Distribution Channel, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
3M Company, Almirall SA, Bausch Health Companies Inc., Biofrontera Inc., BioLineRx Ltd., Cipher Pharmaceuticals Inc, Galderma SA, Hill Dermaceuticals Inc., LEO Pharma A/S and Sun Pharmaceutical Industries Ltd. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global actinic keratosis treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global actinic keratosis treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global actinic keratosis treatment market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Actinic Keratosis Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Prescription
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 OTC
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Fluorouracil
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Imiquimod
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Diclofenac
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Stores and Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Almirall SA
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bausch Health Companies Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Biofrontera Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 BioLineRx Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Cipher Pharmaceuticals Inc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Galderma SA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Hill Dermaceuticals Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 LEO Pharma A/S
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Sun Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Actinic Keratosis Treatment Market: Major Drivers and Challenges
Figure 2: Global: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: Actinic Keratosis Treatment Market: Breakup by Type (in %), 2020
Figure 5: Global: Actinic Keratosis Treatment Market: Breakup by Drug Type (in %), 2020
Figure 6: Global: Actinic Keratosis Treatment Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Global: Actinic Keratosis Treatment Market: Breakup by Region (in %), 2020
Figure 8: Global: Actinic Keratosis Treatment (Prescription) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Actinic Keratosis Treatment (Prescription) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Actinic Keratosis Treatment (OTC) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Actinic Keratosis Treatment (OTC) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Actinic Keratosis Treatment (Fluorouracil) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Actinic Keratosis Treatment (Fluorouracil) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Actinic Keratosis Treatment (Imiquimod) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Actinic Keratosis Treatment (Imiquimod) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Actinic Keratosis Treatment (Diclofenac) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Actinic Keratosis Treatment (Diclofenac) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Actinic Keratosis Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Actinic Keratosis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Actinic Keratosis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Actinic Keratosis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Actinic Keratosis Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Actinic Keratosis Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Actinic Keratosis Treatment (Online Stores) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Actinic Keratosis Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: North America: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: North America: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: United States: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: United States: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Canada: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Canada: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Asia-Pacific: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Asia-Pacific: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: China: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: China: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Japan: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Japan: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: India: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: India: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: South Korea: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: South Korea: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Australia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Australia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Indonesia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Indonesia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Europe: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Europe: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Germany: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Germany: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: France: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: France: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: United Kingdom: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: United Kingdom: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Italy: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Italy: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Spain: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Spain: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Russia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Russia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Latin America: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Latin America: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Brazil: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Brazil: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Mexico: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Mexico: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Middle East and Africa: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Middle East and Africa: Actinic Keratosis Treatment Market: Breakup by Country (in %), 2020
Figure 74: Middle East and Africa: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Global: Actinic Keratosis Treatment Industry: SWOT Analysis
Figure 76: Global: Actinic Keratosis Treatment Industry: Value Chain Analysis
Figure 77: Global: Actinic Keratosis Treatment Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Actinic Keratosis Treatment Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
Table 4: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Actinic Keratosis Treatment Market: Competitive Structure
Table 7: Global: Actinic Keratosis Treatment Market: Key Players